BEIJING, March 28 (Xinhuanet) -- A new drug named
Yervoy has been developed in the U.S. to prolong the lives of people
with the skin cancer melanoma, according to media reports Monday.

Developed by Bristol-Myers Squibb, Yervoy is in a new class of drugs
designed to fight cancer by removing molecular brakes that prevent
immune system cells from destroying tumors.

Approved by the Food and Drug Administration, Yervoy is hailed
by experts as the first drug in the melanoma field that could extend
survival in a meaningful way.